Fungal Infections. Alessandro Diana November 22th 2007

Size: px
Start display at page:

Download "Fungal Infections. Alessandro Diana November 22th 2007"

Transcription

1 Fungal Infections Alessandro Diana November 22th 2007

2 Topics Aspergillosis Candidiasis Cryptococcosis Histoplasmosis Coccidioidomycosis Blastomyocosis Sporotrichosis Pneumocystis jiroveci

3 Aspergillosis - Aspergillus Very common:compost heaps, airbone dust Usually affects the lungs and sinuses Less often: very agressive, spread troughout the lungs and bloostream to brain and kidneys

4 Aspergillosis Symptoms & Diagnosis May cause no symptoms (fungus ball Rx) Reapeted coughing up of blood (severe bleeding) Fever Chest pain Difficulty breathing

5 Aspergillosis - Symptoms & Diagnosis Can affect deeper tissues: 1. Renal failure 2. Liver failure 3. Shock 4. Delirium 5. Bood clots 6. Death can occur quickly Chest x-ray Computed tomography (CT) Whenever possible : send material to a laboratory to confirm identification!

6 Aspergillosis- Prognosis & Treatment When present in a sinus or single spot in he lung progresses SLOWLY Requires treatment, but no immediate danger If infection widespread: patient is seriously ill Voriconazole Amphotericin b Itraconazole Capsofungin

7 Aspergillosis- Prognosis & Treatment If fungus balls grow near lungs blood vessels removed surgically Sinuses aspergillosis removed surgically Ear canal infection scraping out the fungus and topics antifungal drops

8 Acute invasive aspergillosis Allergic aspergillosis Allergic sinusitis Frequency of aspergillosis Frequency of aspergillosis Immune malfunction Aspergilloma Normal immune function Immune hyper-reactivity Courtesy: Prof. A. Gervaix

9 Candidiasis Candida species Normally present on the skin, intestinal tract and genital region. Can cause infection of the skin or the mucous membranes of the mouth or vagina (immunocompetent)

10 Candidiasis Symptoms & Diagnosis These infections are more common in patients with: 1. Cancer 2. AIDS 3. Diabetes 4. Pregnant women

11 Candidiasis Symptoms & Diagnosis Candidiasis also common with patients who are given antibiotics Patients with a weakend immune system develop candidiasis that spreads trough the bloodstream to other part of the body

12 Candidiasis Symptoms & Diagnosis Infection of the mouth (trush) causes creamy, white and painful patches inside the mouth Patches in the esophagus cause pain with swallowing

13 Candidiasis Symptoms & Diagnosis Endocarditis causes: 1. Fever 2. Heart murmur 3. Spleen enlargement

14 Candidiasis Symptoms & Diagnosis Ophtalmic infection (Retinitis) 1. Blindness - Candidemia and kidney infection 1. Fever 2. Very low pressure (shock) 3. Decrease urine production

15 Congenital Cutaneous Candida (CCC) Usually self limited disease Some experts : treatment (fluconazole) highly recommended for prematures < 1000 g

16 Candidiasis Symptoms & Diagnosis To confirm the diagnosis: identify the fungi 1. Skin sample 2. Blood culture 3. Spinal culture cultured on the fungi «milieu»

17 Candidiasis Prognosis & Treatment Skin infection Topical ttt: clotrimotazole Mouth infection (trush) Topical nystatin supsension Vulvovaginal candidiasis Topical vaginal cream OR fluconazole 12 mg/kg (max 150 mg x1.

18 Candidiasis Prognosis & Treatment Endocarditis Retinitis Candidemia (blood infection) Kidney infection

19 Cryptococcosis Symptoms & Diagnosis Cryptococcus neoformans Infection relatevely rare until AIDS epidemics Sometimes infects people with: 1. Hodgkin s disease 2. Sarcoidosis 3. Long term corticosteroids treatment

20 Cryptococcosis Symptoms & Diagnosis Cryptococcosis produces mild and vague symptoms Meningitis: headache & confusion Lung infection: cough, aching chest (!) or poor symptomatic Skin: nodules

21 Cryptococcosis Prognosis & Treatment Immunocompetent patients with cryptococcosis in a small part of their lung usually do not require any treatment. Patient with weakened immune system or severe disease: Fluconazole, Am-B, flucytosine

22 Histoplasmosis Symptoms & Diagnosis Histoplasma capsulatum Infection occurs mainly in the lungs! Spores present in the soil Farmers are most likely to inhale the spores Patients with AIDS are prone to develop histoplasmosis

23 Histoplasmosis Symptoms & Diagnosis Most people with histoplasmosis do not have any symptoms However 3 forms do cause symptoms: 1. Acute h. 2. Progressive disseminated h. 3. Chronic cavitary h.

24 Histoplasmosis Symptoms & Diagnosis Acute: 3-21 days. Patient feels sick, fever, coughing. Self limited disease (2-6 weeks) Progressive disseminated: Does not normally affect healthy adults! Patients with weakened immune system (AIDS, ) Spleen, liver and lymph nodes may enlarge If adrenal glands damaged: Addison!!! Without treatment: fatal in 90% of people! Chronique cavitary Lung infection. Develops gradually ove several weeks Lund damages or fungal invasion may cause death.

25 Histoplasmosis Prognosis & Treatment Acute: usually no treatment Progressive disseminated: Amphotericin B or itraconazole Chronic cavitary: Amphotericin B or itraconazole

26 Coccidioidomycosis Symptoms & Diagnosis Coccidioides immitis Southwest US, Central America, South America Infection occurs mainly in the lungs! Spores present in the soil Farmers are most likely to inhale the spores Patients with AIDS are prone to develop histoplasmosis

27 Coccidioidomycosis Symptoms & Diagnosis Most people with acute primary infection have no symptoms. If so, symptoms appear 1-3 weeks after infection Cough, fever, chills, chest pain, shortness of breath Cough may produce sputum and/or blood Some people develop 1. Conjuntivitis 2. Arthritis 3. Skin nodules

28 Coccidioidomycosis Prognosis & Treatment Acute primary infection typically goes away without treatment. For lung disease: fluconazole (oral) Amphotericin B given with the progressive form of the disease

29 Blastomycosis Symptoms & Diagnosis Blastomyces dermatitidis Spores enter the body trough the airways Lungs primarily affected Most infections occur in the U.S (Southwest and Missisipi River valley)

30 Blastomycosis Symptoms & Diagnosis Fever, chills, drenching sweats. Chest pain Cough, difficulty breathing Lung infection progresses slowly When blastomycosis spreads it affects many areas of the body (skin, bones and genitourinary tract.

31 Blastomycosis Prognosis & Treatment Amphotericine B or itraconazole (oral) With ttt the patient will feel better quickly, but ttt must be continued for months (2-6)

32 Sporotrichosis Symptoms & Diagnosis Sporothrix schenckii Grows on rosebushes, barberry bushes and other mulches. Farmers, gardeners are usually infected from a small puncture wound.

33 Sporotrichosis Symptoms & Diagnosis Infection starts on a finger as a small nontender bump the slowly enlarges and forms a sore. Spreads through the lymphatic vessels, forming nodules and sores along the way. Usually no other symptoms Infection of the lungs causes penumonia Usually in patients with other lung diseases (emphysema) Joint infection produces swelling and pain

34 Sporotrichosis Prognosis & Treatment Skin infection: itraconazole Lung & bone infection: itraconazole or Amphotericin B

35 Pneumocystis jiroveci Symptoms & Diagnosis From the time of its discovery, until late in the 1980s, Pneumocystis carinii was widely thought to be a protozoan. The organism that causes human PCP is now named Pneumocystis jiroveci

36 Pneumocystis jiroveci Prognosis & Treatment TMP/SMX mg/kg/div q8h IV x 2 wks or Pentamidine isethionate 4 mg/kg/d IV Use steroids for more severe disease

37 Choosing among antifungal agents: Polyene antifungal antibiotic (1960) The most broad spectrum antifungal for clinical use Renal dysfunction: decreased glomerular filtration + tubular nephropathy Decrased toxicity with lipid formulation (higher cost) Nystatin for topical use Action on the membrane Amphotericin B

38 Choosing among antifungal agents: Azoles are fungistatic Ketoconazole (1981) Fluconazole, active against broader ranger of fungi (Cryptococcus, Coccidioides, Histoplasma) Despite many resistances in nonalbicans Candida, fluconazone remains the safest systemic antifungal agent of most Candida infections Toxicity unusual (hepatic) Azoles

39 Choosing among antifungal agents: Itraconazole: active against broader range (fungi & moulds) including Aspergillus Azoles Voriconazole: the most recent triaole FDA approved (May 2002) Although not FDA.approved in < 12 yrs, published suggest superior efficacy in the treatment of fver and neutropenia and in ttt of invasice Aspergillus infections in adults

40 Choosing among antifungal agents: New class of systemic agents approved in 2001 Inhibit the glucan synthesis (cell wall formation) Capsofungin: active against most Candida species and Aspergillus. Little data in children Given a site of activity, combination therapyis being actively investigated Micafungin (2005) under study in pediatric population Echinocandins

41 Choosing among antifungal agents: Inhibits fungal protein synthesis by replacing uracil with 5-flurouracil in fungal RNA. Also inhibits thymidylate synthetase via 5- fluorodeoxy-uridine monophosphate and thus interferes with fungal DNA synthesis Flucytosine

42 Preferred therapy for specific fungal pathogens Aspergillosis Candidiasis (disseminated infection) Candidiasis (urinary infection) Candidiasis - oropharyngeal Therapy Voriconazole 14 mg/kg/d IV, PO 400 mg/d bid in children 2-12 yrs (6 weeks) Alternative: AmB LP 5-10 mg/kg/d IV Itraconazole (PO IV) for less severe (non CNS) disease AmB-LP 3-5 mg/kg/d IV Fluconazole 6-12 mg/kg/d IV, PO x 2-4 wks Kg/d PO div q 6H Fluconazole 3-6 mg/ once daily IV or PO x 7 days Clotrimazole 10 mg PO 4-5 times /d X 7 days; or fluconazole 3-6 mg/kg Comments Treat for tissue invasion, NOT colonization Porvides better response than AmB For immune-compromised children start with AmB as some Candida are R to fluconazole (C. Kruzei) Removing catheter, il present may lead to a spontaneous cure in normal host Check for upper UTI AmB IV or capsofungin or fluconazole IV for severe disease or febrile neutropenic patients Adapted from Nelson s Pocket Book of Pediatric Antimicrobial Therapy,

43 Preferred therapy for specific fungal pathogens Therapy Cryptococcosis Pulmonary disease :Fluconazole mg/lk/d IV, PO q24h x 6-12 wks or AmB- LP 3-5 mg/kg/d q 24H Meningitis: AmB LP 3-5 mg/kg/d q 24H AND flucytosine 100 mg/kg/d PO div q 6H y 6 wks OR fluconazole mg/kg/d IV, PO q 24H x 6 wks Coccidioidomycosis Pulmonary disease : AmB LP 3-5 mg/kg/d q 24H OR Fluconazole 6-12 mg/lk/d IV, PO q24h Meningitis: Fluconazole 12 mg/lk/d IV, PO q24h Osteomyelitis : itraconazole 5-10 mg/kg/d q 24H Comments Monitor flucytosine concentrations to keep peaks less than to prevent neutropenia Mild pulmonary disease does not require therapy in the normal host Watch for relapse up to 1-2 yrs after therapy Histoplasmosis AmB LP 3-5 mg/kg/d q 24H OR itraconazole 5 mg/kg/d q 24 H x 6-12 wks Mild disease may not require therapy Pneumocystis jirevoci pneumonia Serious disease : TMP/SMX mg/kd/d div q 8H OR pentamidine 4mg/kg/d x 2 wks Use steroids for more severe disease Adapted from Nelson s Pocket Book of Pediatric Antimicrobial Therapy,

44 Thank your for your attention

Common Fungi. Catherine Diamond MD MPH

Common Fungi. Catherine Diamond MD MPH Common Fungi Catherine Diamond MD MPH Birth Month and Day & Last Four Digits of Your Cell Phone # BEFORE: http://tinyurl.com/kvfy3ts AFTER: http://tinyurl.com/lc4dzwr Clinically Common Fungi Yeast Mold

More information

Fungal infection in the immunocompromised patient. Dr Kirsty Dodgson

Fungal infection in the immunocompromised patient. Dr Kirsty Dodgson Fungal infection in the immunocompromised patient Dr Kirsty Dodgson Aims Discuss different types of fungi Overview of types of clinical infections Clinical Manifestations Fungus Includes Moulds Aspergillus

More information

Condition First line Alternative Comments Candidemia Nonneutropenic adults

Condition First line Alternative Comments Candidemia Nonneutropenic adults Recommendations for the treatment of candidiasis. Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America. Condition First line Alternative

More information

Fungal Diseases of the Respiratory System

Fungal Diseases of the Respiratory System Fungal Diseases of the Respiratory System Histoplasmosis(cave disease) Dr. Hala Al Daghistani Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. Histoplasma capsulatum, is usually

More information

Antifungal drugs Dr. Raz Muhammed

Antifungal drugs Dr. Raz Muhammed Antifungal drugs 13. 12. 2018 Dr. Raz Muhammed 2. Flucytosine (5-FC) Is fungistatic Is a synthetic pyrimidine antimetabolite Is often used in combination with amphotericin B in the treatment of systemic

More information

Cigna Drug and Biologic Coverage Policy

Cigna Drug and Biologic Coverage Policy Cigna Drug and Biologic Coverage Policy Subject Voriconazole Effective Date... 3/15/2018 Next Review Date... 3/15/2019 Coverage Policy Number... 4004 Table of Contents Coverage Policy... 1 General Background...

More information

Fungal update. Liise-anne Pirofski, M.D. Albert Einstein College of Medicine

Fungal update. Liise-anne Pirofski, M.D. Albert Einstein College of Medicine Liise-anne Pirofski, M.D. Albert Einstein College of Medicine Fungal update http://clicks.robertgenn.com/miss-potter.php http://letterfromhere.blogspot.com/2007/06/beatrix-potters-jog-trot-through.html

More information

Fungi are eukaryotic With rigid cell walls composed largely of chitin rather than peptidoglycan (a characteristic component of most bacterial cell

Fungi are eukaryotic With rigid cell walls composed largely of chitin rather than peptidoglycan (a characteristic component of most bacterial cell Antifungal Drugs Fungal infections (Mycoses) Often chronic in nature. Mycotic infections may be superficial and involve only the skin (cutaneous mycoses extending into the epidermis) Others may penetrate

More information

Case Studies in Fungal Infections and Antifungal Therapy

Case Studies in Fungal Infections and Antifungal Therapy Case Studies in Fungal Infections and Antifungal Therapy Wayne L. Gold MD, FRCPC Annual Meeting of the Canadian Society of Internal Medicine November 4, 2017 Disclosures No financial disclosures or industry

More information

Fungal biology. Fungal Infections. Fungal cell structure. Pathogenesis

Fungal biology. Fungal Infections. Fungal cell structure. Pathogenesis Fungal Infections Once exotic and rare; now increasingly common Fungi are not virulent But they are good at taking advantage Opportunistic in many senses Fungal biology Eukaryotic (organized nucleus and

More information

Current Options in Antifungal Pharmacotherapy

Current Options in Antifungal Pharmacotherapy Current Options in Antifungal Pharmacotherapy John Mohr, Pharm.D., Melissa Johnson, Pharm.D., Travis Cooper, Pharm.D., James S. Lewis, II, Pharm.D., and Luis Ostrosky-Zeichner, M.D. Infections caused by

More information

Fungal biology. Pathogenesis. Fungal cell structure. Fungal Infections MID 25 & 26. Eukaryotic (organized nucleus and cell structure) Non-motile

Fungal biology. Pathogenesis. Fungal cell structure. Fungal Infections MID 25 & 26. Eukaryotic (organized nucleus and cell structure) Non-motile Fungal Infections Once exotic and rare; now increasingly common Fungi are not virulent But they are good at taking advantage Opportunistic in many senses Fungal biology Eukaryotic (organized nucleus and

More information

Lecture 7: Mycoses Caused by Dimorphic Fungi, Part I

Lecture 7: Mycoses Caused by Dimorphic Fungi, Part I BIOL 4849 Medical Mycology Summer 2006 Histoplasmosis Lecture 7: Mycoses Caused by Dimorphic Fungi, Part I u Most common endemic mycotic disease in the United States u Two different varieties (actually

More information

Antifungals and current treatment guidelines in pediatrics and neonatology

Antifungals and current treatment guidelines in pediatrics and neonatology Dragana Janic Antifungals and current treatment guidelines in pediatrics and neonatology Dragana Janic. University Children`s Hospital, Belgrade, Serbia 10/10/17 Hotel Crowne Plaza, Belgrade, Serbia; www.dtfd.org

More information

Title: Author: Speciality / Division: Directorate:

Title: Author: Speciality / Division: Directorate: Antifungal guidelines for CANDIDIASIS INFECTIONS (Adults) Proven infection: Targeted antifungal therapy should be prescribed for: o Positive cultures from a sterile site with clinical or radiological abnormality

More information

Epidemiology and ecology of fungal diseases

Epidemiology and ecology of fungal diseases Epidemiology and ecology of fungal diseases Healthcare Focus on: - individual - diagnosis - treatment Public Health Focus on: - population - prevention The nature of fungi Kingdom Fungi (lat. fungus, -i)

More information

Antifungal Agents. Polyenes Azoles Allyl and Benzyl Amines Other antifungals

Antifungal Agents. Polyenes Azoles Allyl and Benzyl Amines Other antifungals OPTO 6434 General Pharmacology Antifungal Agents Dr. Alison McDermott Room 254 HBSB, Phone 713-743 1974 Email amcdermott@optometry.uh.edu Fall 2015 Reading: Chapter 50 Brody s Human Pharmacology by Wecker

More information

Updated Guidelines for Management of Candidiasis. Vidya Sankar, DMD, MHS April 6, 2017

Updated Guidelines for Management of Candidiasis. Vidya Sankar, DMD, MHS April 6, 2017 Updated Guidelines for Management of Candidiasis Vidya Sankar, DMD, MHS April 6, 2017 Statement of Disclosure I have no actual or potential conflict of interest in relation to this presentation Outline

More information

MANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS

MANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS MANAGEMENT OF HOSPITAL-ACQUIRED FUNGAL INFECTIONS Paul D. Holtom, MD Associate Professor of Medicine and Orthopaedics USC Keck School of Medicine Numbers of Cases of Sepsis in the United States, According

More information

Pathogens with Intermediate Virulence Dermatophytes opportunistic Pathogens

Pathogens with Intermediate Virulence Dermatophytes opportunistic Pathogens Pathogens with Intermediate Virulence Dermatophytes opportunistic Pathogens Cryptococcus neoformans Candida albicans Aspergillus species Pneumocystis carinii 1 Dermatophytes Named for derma skin Cause

More information

MENINGITIS CRYPTOCOCCAL. learn about the symptoms, diagnosing and treating this disease

MENINGITIS CRYPTOCOCCAL. learn about the symptoms, diagnosing and treating this disease CRYPTOCOCCAL MENINGITIS learn about the symptoms, diagnosing and treating this disease A PUBLICATION FROM Information, Inspiration and Advocacy for People Living With HIV/AIDS JANAURY 2007 Cryptococcal

More information

Case 1. Background. Presenting Symptoms. Schecter Case1 Differential Diagnosis of TB 1

Case 1. Background. Presenting Symptoms. Schecter Case1 Differential Diagnosis of TB 1 TB or Not TB? Case 1 Gisela Schecter, M.D., M.P.H. California Department of Public Health Background 26 year old African American male Born and raised in Bay Area of California Convicted of cocaine trafficking

More information

Introduction. Study of fungi called mycology.

Introduction. Study of fungi called mycology. Fungi Introduction Study of fungi called mycology. Some fungi are beneficial: ex a) Important in production of some foods, ex: cheeses, bread. b) Important in production of some antibiotics, ex: penicillin

More information

ANTIMYCOTIC DRUGS Modes of Action

ANTIMYCOTIC DRUGS Modes of Action ANTIMYCOTIC DRUGS Modes of Action Prapasarakul Nuvee, D.V.M., Ph.D. Department of Veterinary Microbiology, Faculty of Veterinary Science, Chulalongkorn University 1 What drugs act as antifungal agents?

More information

Histoplasmosis. Disease Etiology: Disease Transmission: Reservoirs: Specific Microbial Characteristics: By: Ernest Aguilar

Histoplasmosis. Disease Etiology: Disease Transmission: Reservoirs: Specific Microbial Characteristics: By: Ernest Aguilar Histoplasmosis By: Ernest Aguilar Disease Etiology: Histoplasmosis is an infection resulting from the inhalation of spores belonging to the fungus Histoplasma capsulatum. [1] This one of three fungi that

More information

Elements for a Public Summary. [Product Name] 40 mg/ml oral suspension. VI.2.1 Overview of disease epidemiology

Elements for a Public Summary. [Product Name] 40 mg/ml oral suspension. VI.2.1 Overview of disease epidemiology VI.2 Elements for a Public Summary [Product Name] 40 mg/ml oral suspension VI.2.1 Overview of disease epidemiology Fungi (yeasts) are small organisms that feed by breaking down tissue. In humans, fungi

More information

North American Endemic Fungi

North American Endemic Fungi North American Endemic Fungi Boni Elizabeth Elewski, MD Chair Department of Dermatology University of Alabama at Birmingham James Elder Professor of Graduate Medical Education DISCLOSURE OF FINANCIAL RELATIONSHIPS

More information

Chapter 18. Fungal Diseases of the Lung. Mosby items and derived items 2011, 2006 by Mosby, Inc., an affiliate of Elsevier Inc.

Chapter 18. Fungal Diseases of the Lung. Mosby items and derived items 2011, 2006 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 18 Fungal Diseases of the Lung 1 YLS S M AC Figure 18-1. Fungal disease of the lung. Cross-sectional view of alveoli infected with Histoplasma capsulatum. AC, alveolar consolidation; M, alveolar

More information

Fungi. Eucaryotic Rigid cell wall(chitin, glucan) Cell membrane ergosterol Unicellular, multicellular Classic fungus taxonomy:

Fungi. Eucaryotic Rigid cell wall(chitin, glucan) Cell membrane ergosterol Unicellular, multicellular Classic fungus taxonomy: MYCOLOGY Mycology I Fungi Eucaryotic Rigid cell wall(chitin, glucan) Cell membrane ergosterol Unicellular, multicellular Classic fungus taxonomy: Morphology Spore formation FFungi Yeast Mold Yeastlike

More information

Rheem Totah, Office H172M, Ph Office hours MWF 11:30 12:20 or by arrangement

Rheem Totah, Office H172M, Ph Office hours MWF 11:30 12:20 or by arrangement Rheem Totah, Office H172M, Ph 206-543-9481 rtotah@uw.edu Office hours MWF 11:30 12:20 or by arrangement Date/Time Topic Readings Mon March 26 Antifungal agents Foye s Chapter 40 Wed March 28 Antifungal

More information

Ali Alabbadi. Sarah Jaar ... Nader

Ali Alabbadi. Sarah Jaar ... Nader 24 Ali Alabbadi Sarah Jaar... Nader Intro to Mycology *underlined text was explained in the lecture but is not found in the slides -mycology: the study of the mycoses of man (fungal infections) -less than

More information

TOWARDS PRE-EMPTIVE? TRADITIONAL DIAGNOSIS. GALACTOMANNAN Sensitivity 61% Specificity 93% Neg Predict Value >95% β-d-glucan Neg Predict Value 100% PCR

TOWARDS PRE-EMPTIVE? TRADITIONAL DIAGNOSIS. GALACTOMANNAN Sensitivity 61% Specificity 93% Neg Predict Value >95% β-d-glucan Neg Predict Value 100% PCR TOWARDS PRE-EMPTIVE? GALACTOMANNAN Sensitivity 61% Specificity 93% Neg Predict Value >95% TRADITIONAL DIAGNOSIS β-d-glucan Neg Predict Value 100% PCR diagnostics FUNGAL BURDEN FIRST TEST POSITIVE FOR ASPERGILLOSIS

More information

ADEQUATE ANTIFUNGAL USE FOR BLOODSTREAM INFECTIONS

ADEQUATE ANTIFUNGAL USE FOR BLOODSTREAM INFECTIONS ADEQUATE ANTIFUNGAL USE FOR BLOODSTREAM INFECTIONS COMMERCIAL RELATIONS DISCLOSURE 2500 9000 15000 Astellas Gilead Sciences Pfizer Inc Expert advice Speaker s bureau Speaker s bureau OUTLINE OF THE PRESENTATION

More information

Fungal Meningitis. Stefan Zimmerli Institute for infectious diseases University of Bern Friedbühlstrasse Bern

Fungal Meningitis. Stefan Zimmerli Institute for infectious diseases University of Bern Friedbühlstrasse Bern Fungal Meningitis Stefan Zimmerli Institute for infectious diseases University of Bern Friedbühlstrasse 51 3010 Bern Death due to infectious diseases in sub-saharan Africa Park BJ. Et al AIDS 2009;23:525

More information

An Update in the Management of Candidiasis

An Update in the Management of Candidiasis An Update in the Management of Candidiasis Daniel B. Chastain, Pharm.D., AAHIVP Infectious Diseases Pharmacy Specialist Phoebe Putney Memorial Hospital Adjunct Clinical Assistant Professor UGA College

More information

Med Chem 401: Mycology (www.doctorfungus.org) Mycology

Med Chem 401: Mycology (www.doctorfungus.org) Mycology Med Chem 401: Mycology (www.doctorfungus.org) Mycology is the Study of Fungi (Monera, Protoctista, Fungi, Plantae, Animalia). Fungi are eukaryotic cells and as such contain nuclei, mitochondria, ER, golgi,

More information

Antimycotics. November 14, Jan Strojil. Ústav farmakologie LF UP

Antimycotics. November 14, Jan Strojil. Ústav farmakologie LF UP Ústav farmakologie LF UP November 14, 2005 Introduction Polyens Azoles Alylamines Other Outline Introduction Polyens Azoles Alylamines and morfolines Other Introduction Polyens Azoles Alylamines Other

More information

Management of fungal infection

Management of fungal infection Management of fungal infection HKDU symposium 17 th May 2015 Speaker: Dr. Thomas Chan MBBS (Hons), MRCP, FHKCP, FHKAM Synopsis Infection caused by fungus mycoses Skin infection by fungus is common in general

More information

Antimicrobials; antibacterials, antifungals, antiprotozoans, antivirals, and antihelminthics 6

Antimicrobials; antibacterials, antifungals, antiprotozoans, antivirals, and antihelminthics 6 Antimicrobials; antibacterials, antifungals, antiprotozoans, antivirals, and antihelminthics 6 Inhibition of Ergosterol Synthesis Azoles Miconazole Triazoles Allylamines For azole-resistant infections

More information

Bloodborne Pathogens. Introduction to Fungi. Next >> COURSE 2 MODULE 4

Bloodborne Pathogens. Introduction to Fungi. Next >> COURSE 2 MODULE 4 Bloodborne Pathogens COURSE 2 MODULE 4 to is a general term used to encompass the diverse morphologic forms of yeasts and molds. Originally classified as primitive plants without chlorophyll, the fungi

More information

Current options of antifungal therapy in invasive candidiasis

Current options of antifungal therapy in invasive candidiasis Current options of antifungal therapy in invasive candidiasis Saloua Ladeb Bone Marrow Transplant Center Tunis HAMMAMET 24 th April 2012 DEFINITION One or more positive results on blood culture for Candida

More information

Case. Fungal infections for the community provider. Case. Case. April 25, 2014 Peter V. Chin-Hong M.D. Infectious Diseases UCSF UCSF

Case. Fungal infections for the community provider. Case. Case. April 25, 2014 Peter V. Chin-Hong M.D. Infectious Diseases UCSF UCSF Case Fungal infections for the community provider April 25, 2014 Peter V. Chin-Hong M.D. Infectious Diseases UCSF peter.chin-hong@ucsf.edu UCSF A 38-year-old African-American female financial analyst is

More information

Course content. Chemotherapeutic agents

Course content. Chemotherapeutic agents Course content 1 Chemotherapeutic agents Mechanism of actions Indications Contraindications/Cautions Drug interactions Side-effects/Adverse reactions Dosage regimen (occasionally) Reference Books 2 Pharmacology

More information

Antifungal Update 2/22/12. Which is the most appropriate initial empirical therapy in a candidemic patient?

Antifungal Update 2/22/12. Which is the most appropriate initial empirical therapy in a candidemic patient? Antifungal Update B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy School of Pharmacy University of California San Francisco 3/3 blood cultures are positive for an unidentified

More information

Antifungal Update. Candida: In Vitro Antifungal Susceptibility Testing

Antifungal Update. Candida: In Vitro Antifungal Susceptibility Testing Antifungal Update B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy School of Pharmacy University of California San Francisco The patient spikes a new fever and 3/3 blood

More information

How does my new treatment work?

How does my new treatment work? How does my new treatment work? Get to know KEVZARA better. Click here for full Prescribing Information including 1 risk of SERIOUS SIDE EFFECTS and Medication Guide. You're starting KEVZARA... GOT A QUESTION?

More information

JUST FOR KIDS SELECTED IMPORTANT SAFETY INFORMATION

JUST FOR KIDS SELECTED IMPORTANT SAFETY INFORMATION JUST FOR KIDS For children ages 6-17 with moderately to severely active Crohn s disease or ulcerative colitis (UC) who haven t responded well to other therapies SELECTED IMPORTANT SAFETY INFORMATION REMICADE

More information

Management Strategies For Invasive Mycoses: An MD Anderson Perspective

Management Strategies For Invasive Mycoses: An MD Anderson Perspective Management Strategies For Invasive Mycoses: An MD Anderson Perspective Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA Professor of Medicine Director of Mycology Research Program M. D. Anderson Cancer

More information

Antifungal therapies differences in agents

Antifungal therapies differences in agents Antifungal therapies differences in agents The basic Fungi are eukaryotes Eukaryote = an organism whose cells contain complex structures enclosed within membrane. Most Common Fungal Pathogens Dermatophytes

More information

Fungal Infections. Fungal Infections

Fungal Infections. Fungal Infections Fungal Infection in the Immune Competent Host Steven L. Primack, MD Fungal Infection in the Immune Competent Host Steven L. Primack, MD Department of Radiology Oregon Health & Science University Fungal

More information

WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS?

WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS? WHICH ANTIFUNGAL AGENT IS THE CHOICE FOR SUSPECTED FUNGAL INFECTIONS? Assoc. Prof. Dr. Serkan SENER Acibadem University Medical School Department of Emergency Medicine, Istanbul Acibadem Ankara Hospital,

More information

Itraconazole DIGICON. Composition: MOLECULAR INTRODUCTION

Itraconazole DIGICON. Composition: MOLECULAR INTRODUCTION Itraconazole DIGICON Composition: Itraconazole 100 mg MOLECULAR INTRODUCTION Itraconazole is a triazole medicine used to treat fungal infections. It is effective against a broad spectrum of fungi including:

More information

ECMM Excellence Centers Quality Audit

ECMM Excellence Centers Quality Audit ECMM Excellence Centers Quality Audit Person in charge: Department: Head of Department: Laboratory is accredited according to ISO 15189 (Medical Laboratories Requirements for quality and competence) Inspected

More information

Current and Emerging Azole Antifungal Agents

Current and Emerging Azole Antifungal Agents CLINICAL MICROBIOLOGY REVIEWS, Jan. 1999, p. 40 79 Vol. 12, No. 1 0893-8512/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Current and Emerging Azole Antifungal Agents

More information

Antifungal Update 2/24/11. Which is the most appropriate initial empirical therapy in a candidemic patient?

Antifungal Update 2/24/11. Which is the most appropriate initial empirical therapy in a candidemic patient? Antifungal Update B. Joseph Guglielmo, Pharm.D. Professor and Chair Department of Clinical Pharmacy School of Pharmacy University of California San Francisco The patient spikes a new fever and 3/3 blood

More information

Judith A. Aberg, MD; Linda M. Mundy, MD; and William G. Powderly, MD

Judith A. Aberg, MD; Linda M. Mundy, MD; and William G. Powderly, MD Pulmonary Cryptococcosis in Patients Without HIV Infection* Judith A. Aberg, MD; Linda M. Mundy, MD; and William G. Powderly, MD Purpose: To further elucidate the diagnostic and therapeutic approaches

More information

Fungal infections in ICU. Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia

Fungal infections in ICU. Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia Fungal infections in ICU Tang Swee Fong Department of Paediatrics Universiti Kebangsaan Malaysia Epidemiology of invasive fungal infections - US +300% Martin GS, et al. N Engl J Med 2003;348:1546-1554

More information

Use of Antifungal Drugs in the Year 2006"

Use of Antifungal Drugs in the Year 2006 Use of Antifungal Drugs in the Year 2006" Jose G. Montoya, MD Associate Professor of Medicine Associate Chief for Clinical Affairs Division of Infectious Diseases Stanford University School of Medicine

More information

ESCMID Online Lecture Library. by author. CASE PRESENTATION ECCMID clinical grand round May Anat Stern, MD Rambam medical center Haifa, Israel

ESCMID Online Lecture Library. by author. CASE PRESENTATION ECCMID clinical grand round May Anat Stern, MD Rambam medical center Haifa, Israel CASE PRESENTATION ECCMID clinical grand round May 2014 Anat Stern, MD Rambam medical center Haifa, Israel An 18 years old Female, from Ukraine, diagnosed with acute lymphoblastic leukemia (ALL) in 2003.

More information

number Done by Corrected by Doctor د.حامد الزعبي

number Done by Corrected by Doctor د.حامد الزعبي number Fungi#1 Done by نرجس الس ماك Corrected by مهدي الشعراوي Doctor د.حامد الزعبي Introduction to Mycology -Terms: -Medical Mycology: The study of mycosis and their etiological agents -Mycosis: Disease

More information

Fungal Infection in the ICU: Current Controversies

Fungal Infection in the ICU: Current Controversies Fungal Infection in the ICU: Current Controversies Andrew F. Shorr, MD, MPH, FCCP, FACP Washington Hospital Center Georgetown University, Washington, DC Disclosures I have served as a consultant to, researcher/investigator

More information

Improving Clinical Outcomes in Fungal Infection Control and Management

Improving Clinical Outcomes in Fungal Infection Control and Management Improving Clinical Outcomes in Fungal Infection Control and Management DISCLAIMER The information within this CME/CE activity is for continuing education purposes only, and is not intended to substitute

More information

CURRENT AND NEWER ANTI-FUNGAL THERAPIES- MECHANISMS, INDICATIONS, LIMITATIONS AND PROBLEMS. Dr AMIT RAODEO DM SEMINAR

CURRENT AND NEWER ANTI-FUNGAL THERAPIES- MECHANISMS, INDICATIONS, LIMITATIONS AND PROBLEMS. Dr AMIT RAODEO DM SEMINAR CURRENT AND NEWER ANTI-FUNGAL THERAPIES- MECHANISMS, INDICATIONS, LIMITATIONS AND PROBLEMS Dr AMIT RAODEO DM SEMINAR Introduction The incidence of invasive fungal infections in critically ill intensive

More information

General History. 林陳 珠 Female 69 years old 住院期間 : ~ Chief Complaint : sudden loss of conscious 5 minutes in the morning.

General History. 林陳 珠 Female 69 years old 住院期間 : ~ Chief Complaint : sudden loss of conscious 5 minutes in the morning. General History 林陳 珠 Female 69 years old 住院期間 : 93.5.8~93.5.15 Chief Complaint : sudden loss of conscious for 2-52 5 minutes in the morning. General History DM under regular medical control for 10 years.

More information

Introduction. Yeast candida, cryptococcus, trichosporon. Filamentous rhizopus, rhizomucor, mucor. Dimorphic Fungi bl t hi t l

Introduction. Yeast candida, cryptococcus, trichosporon. Filamentous rhizopus, rhizomucor, mucor. Dimorphic Fungi bl t hi t l Presenter Vikas Naik Moderator Aditya Gupta Deepak Gupta Introduction Fungi are saphrophytes Yeast candida, cryptococcus, trichosporon Filamentous rhizopus, rhizomucor, mucor Dimorphic Fungi bl t hi t

More information

Update from the Laboratory: Clinical Identification and Susceptibility Testing of Fungi and Trends in Antifungal Resistance 13

Update from the Laboratory: Clinical Identification and Susceptibility Testing of Fungi and Trends in Antifungal Resistance 13 Fungal Infections Preface: Fungal Infections Luis Ostrosky-Zeichner and Jack D. Sobel xiii The Global Burden of Fungal Diseases 1 Snigdha Vallabhaneni, Rajal K. Mody, Tiffany Walker, and Tom Chiller Fungal

More information

Mycology Reference Centre, Leeds Information for Service Users 2017

Mycology Reference Centre, Leeds Information for Service Users 2017 The Leeds Teaching Hospitals NHS Trust NHS Mycology Reference Centre, Leeds Information for Service Users 2017 Contents Contents...1 The Mycology Reference Centre...1 Request Forms... 1 Specimen Transportation...

More information

Antifungal Agents. Prof. Suheil Zmeili Faculty of Medicine Department of Pharmacology University of Jordan

Antifungal Agents. Prof. Suheil Zmeili Faculty of Medicine Department of Pharmacology University of Jordan Antifungal Agents Prof. Suheil Zmeili Faculty of Medicine Department of Pharmacology University of Jordan Antifungal Agents Objectives: - Know Available antifungal drugs - Know their MOA - Know their Pharmacokinetic

More information

When is failure failure?

When is failure failure? When is failure failure? Bart-Jan Kullberg, M.D. Radboud University Nijmegen The Netherlands The ICU patient with candidemia!! Female, 39 years old!! Multiple abdominal surgeries for Crohn's disease!!

More information

Does diflucan work for thrush

Does diflucan work for thrush P ford residence southampton, ny Does diflucan work for thrush 17-1-2018 Diflucan 150 mg capsule contains the antifungal medicine fluconazole. Diflucan 150 capsule is a single dose treatment for vaginal

More information

About the Editor Gerri S. Hall, Ph.D.

About the Editor Gerri S. Hall, Ph.D. About the Editor Gerri S. Hall, Ph.D. Dr. Hall s professional career has been focused on clinical microbiology: direct clinical activities of various areas such as bacteriology, mycobacteria, STD testing,

More information

PAGL Inclusion Approved at January 2017 PGC

PAGL Inclusion Approved at January 2017 PGC Guideline for the prophylaxis and treatment of fungal infections in Haematology patients 1. Introduction PAGL Inclusion Approved at January 2017 PGC Haematology, CHUGGS June 2016 This guideline sets out

More information

What are my treatment support resources?

What are my treatment support resources? What are my treatment support resources? Get help when you need it. Click here for full Prescribing Information including risk of SERIOUS SIDE EFFECTS and Medication Guide. We re here to help you......

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author How To Best Use Antifungal Agents Cornelia Lass-Flörl Division of Hygiene and Medical Microbiology Innsbruck Medical University ESCMID SUMMER SCHOOL 2012 Epidemiology Diagnosis Roadmap Antifungal drugs

More information

Medical Mycology. Dr. Hala Al Daghistani

Medical Mycology. Dr. Hala Al Daghistani Medical Mycology Dr. Hala Al Daghistani Mycotic Infections GENERAL CONCEPTS A. The fungi represent a diverse, heterogeneous group of eukaryotic B. Most of these organisms are plant pathogens and relatively

More information

(Notes on Anti-TB agents are included in the TB syllabus)

(Notes on Anti-TB agents are included in the TB syllabus) (Notes on Anti-TB agents are included in the TB syllabus) Antifungal Agents A. Zuger MD General background: 1. Fungi are eukaryotes, with more cellular similarities to human cells than to bacterial cells.

More information

Royce Johnson, M.D., F.A.C.P. Disclosure Information Research Support/Consultant/Speaker

Royce Johnson, M.D., F.A.C.P. Disclosure Information Research Support/Consultant/Speaker Royce Johnson, M.D., F.A.C.P. Disclosure Information Research Support/Consultant/Speaker Astellas Enzon Pharmaceuticals Merck & Co, Inc. Ortho-McNeil, Inc. Pfizer, Inc. Sanofi Aventis Schering-Plough The

More information

Practice Guidelines for the Management of Patients with Blastomycosis

Practice Guidelines for the Management of Patients with Blastomycosis 679 Practice Guidelines for the Management of Patients with Blastomycosis Stanley W. Chapman, 1 Robert W. Bradsher, Jr., 2 G. Douglas Campbell, Jr., 3 Peter G. Pappas, 4 and Carol A. Kauffman 5 From the

More information

Use of Antifungals in the Year 2008

Use of Antifungals in the Year 2008 Use of Antifungals in the Year 2008 Jose G. Montoya, MD Associate Professor of Medicine Associate Chief for Clinical Affairs Division of Infectious Diseases Stanford University School of Medicine Diagnosis

More information

Fungal infections and critically ill adults

Fungal infections and critically ill adults Martin Beed FRCA FFICM DM Richard Sherman MRCP FRCA FFICM Stephen Holden MSc FRCPath 1A02,2C03 Key points The incidence of fungal diseases in critically ill patients is thought to be increasing, most commonly

More information

Summary of the risk management plan (RMP) for Cresemba (isavuconazole)

Summary of the risk management plan (RMP) for Cresemba (isavuconazole) EMA/576866/2015 Summary of the risk management plan (RMP) for Cresemba (isavuconazole) This is a summary of the risk management plan (RMP) for Cresemba, which details the measures to be taken in order

More information

FOR THE USE ONLY OF A REGISTERED MEDICAL PRACTITIONER OR A HOSPITAL OR A LABORATORY Liposomal Amphotericin B Injection I.P. (LyophilIzed) 50mg

FOR THE USE ONLY OF A REGISTERED MEDICAL PRACTITIONER OR A HOSPITAL OR A LABORATORY Liposomal Amphotericin B Injection I.P. (LyophilIzed) 50mg FOR THE USE ONLY OF A REGISTERED MEDICAL PRACTITIONER OR A HOSPITAL OR A LABORATORY Liposomal Amphotericin B Injection I.P. AMPHONEX (LyophilIzed) 50mg For Intravenous infusion to hospitalized patients

More information

Clinical Manifestations of HIV

Clinical Manifestations of HIV HIV Symptoms Diane Havlir, MD Professor of Medicine and Chief, HIV/AIDS Division University of California, San Francisco (UCSF) WorldMedSchool; July 2, 2013 1 Clinical Manifestations of HIV! Result from

More information

Fungal Infection Pre-Infusion Data

Fungal Infection Pre-Infusion Data Fungal Infection Pre-Infusion Data Registry Use Only Sequence Number: Date Received: CIBMTR Center Number: Event date: / / CIBMTR Form 2046 revision 5 (page 1 of 5). Last Updated May, 2018. Infection Episode

More information

medical monitoring: clinical monitoring and laboratory tests

medical monitoring: clinical monitoring and laboratory tests medical monitoring: clinical monitoring and laboratory tests Purpose of monitoring Check on the physical, psychological and emotional condition of the patient Detect other treatable conditions Identify

More information

MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION

MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSP There are no translations available. MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION

More information

Mycobacteria and fungal infections of the respiratory tract

Mycobacteria and fungal infections of the respiratory tract Before you start: You must read the slides! The Dr. did not bother to explain them all Mycobacteria and fungal infections of the respiratory tract - TB is a global problem that the WHO is trying to combat.

More information

C. albicans C. tropicalis C. parapsilosis C. kefyr C. glabrata C. krusei C. guillermondii C. lusitaniae THERAPY USING ANTIFUNGALS AND ANTIVIRALS

C. albicans C. tropicalis C. parapsilosis C. kefyr C. glabrata C. krusei C. guillermondii C. lusitaniae THERAPY USING ANTIFUNGALS AND ANTIVIRALS THERAPY USING ANTIFUNGALS AND ANTIVIRALS Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington dblack@u.washington.edu CLASSIFICATION OF FUNGI Yeasts Candida Cryptococcus

More information

Alberta Health and Wellness Public Health Disease Under Surveillance Management Guidelines March 2011

Alberta Health and Wellness Public Health Disease Under Surveillance Management Guidelines March 2011 March 2011 Histoplasmosis Case Definition Confirmed Case Clinical illness [1] with laboratory confirmation of infection: Isolation of Histoplasma capsulatum from an appropriate clinical specimen (tissue

More information

Dr Kaniz Fatema. FCPS (Medicine), MD (Critical Care Medicine) Associate Professor Dept of Critical Care Medicine BIRDEM General Hospital

Dr Kaniz Fatema. FCPS (Medicine), MD (Critical Care Medicine) Associate Professor Dept of Critical Care Medicine BIRDEM General Hospital Dr Kaniz Fatema FCPS (Medicine), MD (Critical Care Medicine) Associate Professor Dept of Critical Care Medicine BIRDEM General Hospital 65-years old lady HTN (15 yrs) Adult Still s Disease (2 mon)

More information

8/2/10. Sanaz Jalali, Jennifer Demler, Jeremy King. Histoplasmosis is an intracellular mycotic infection of the reticuloendothelial system.

8/2/10. Sanaz Jalali, Jennifer Demler, Jeremy King. Histoplasmosis is an intracellular mycotic infection of the reticuloendothelial system. Histoplasmosis is an intracellular mycotic infection of the reticuloendothelial system. Type of chronic respiratory infection http://www.eregimens.com/regimens/antifungal%20general.htm Sanaz Jalali, Jennifer

More information

Epidemiology and Laboratory Diagnosis of Fungal Diseases

Epidemiology and Laboratory Diagnosis of Fungal Diseases Medical Mycology (BIOL 4849) Summer 2007 Dr. Cooper Epidemiology of Mycoses Epidemiology and Laboratory Diagnosis of Fungal Diseases Mycosis (pl., mycoses) - an infection caused by a fungus Two broad categories

More information

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health

More information

3/16/16 COCCIDIOIDOMYCOSIS COCCIDIOIDOMYCOSIS COCCIDIOIDOMYCOSIS COCCIDIOIDOMYCOSIS COCCIDIOIDOMYCOSIS COCCIDIOIDOMYCOSIS. Selected References

3/16/16 COCCIDIOIDOMYCOSIS COCCIDIOIDOMYCOSIS COCCIDIOIDOMYCOSIS COCCIDIOIDOMYCOSIS COCCIDIOIDOMYCOSIS COCCIDIOIDOMYCOSIS. Selected References 10 MARCH 2006 Updated 5 June 2008 Updated 11 February 2011 Updated 4 March 2016 Herbert Boro, M.D., F.A.C.P. Selected References 1. Fiese, Marshall J. 1958. Coccidioidomycosis. Charles C. Thomas. 253 pp.

More information

Didactic Series. Fungal Infections: small bother to big mortality

Didactic Series. Fungal Infections: small bother to big mortality Didactic Series Fungal Infections: small bother to big mortality Christian B. Ramers, MD, MPH Family Health Centers of San Diego Ciaccio Memorial Clinic 8/8/13 ACCREDITATION STATEMENT: University of California,

More information

Opportunistic Mycoses

Opportunistic Mycoses CANDIDIASIS SOFYAN LUBIS DEPARTEMEN MIKROBIOLOGI FAK.KEDOKTERAN USU MEDAN 2009 Opportunistic Mycoses Opportunistic mycoses are fungal infections that do not normally cause disease in healthy people, but

More information

Nationwide survey of treatment for pediatric patients with invasive fungal infections in Japan

Nationwide survey of treatment for pediatric patients with invasive fungal infections in Japan J Infect Chemother (2013) 19:946 950 DOI 10.1007/s10156-013-0624-7 ORIGINAL ARTICLE Nationwide survey of treatment for pediatric patients with invasive fungal infections in Japan Masaaki Mori Received:

More information

Invasive Fungal Infections in Solid Organ Transplant Recipients

Invasive Fungal Infections in Solid Organ Transplant Recipients Outlines Epidemiology Candidiasis Aspergillosis Invasive Fungal Infections in Solid Organ Transplant Recipients Hsin-Yun Sun, M.D. Division of Infectious Diseases Department of Internal Medicine National

More information

Blood stream candidiasis. R. Demeester, D. Famerée, B. Guillaume, JC. Legrand CHU Charleroi SBIMC 8th of November 2012

Blood stream candidiasis. R. Demeester, D. Famerée, B. Guillaume, JC. Legrand CHU Charleroi SBIMC 8th of November 2012 Blood stream candidiasis R. Demeester, D. Famerée, B. Guillaume, JC. Legrand CHU Charleroi SBIMC 8th of November 2012 62-year-old man: clinical history Fever for 10 days with peaks above 39 C, cough, orthopnea

More information

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health

More information